Delek US (NYSE:DK) Director Shlomo Zohar Sells 7,343 Shares of Stock

Delek US Holdings, Inc. (NYSE:DK) Director Shlomo Zohar sold 7,343 shares of Delek US stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $43.00, for a total value of $315,749.00. Following the sale, the director directly owned 41,018 shares of the company’s stock, valued at approximately $1,763,774. This trade represents a 15.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shlomo Zohar also recently made the following trade(s):

• On Thursday, March 5th, Shlomo Zohar sold 22,029 shares of Delek US stock. The stock was sold at an average price of $44.83, for a total value of $987,560.07.

Delek US Stock Performance

Shares of Delek US stock opened at $42.35 on Friday. The firm has a market cap of $2.54 billion, a P/E ratio of -121.00 and a beta of 0.75. The company has a current ratio of 0.82, a quick ratio of 0.58 and a debt-to-equity ratio of 5.89. Delek US Holdings, Inc. has a 12 month low of $11.02 and a 12 month high of $45.74. The stock’s fifty day moving average price is $32.38 and its 200-day moving average price is $33.31.

Delek US (NYSE:DK) last released its quarterly earnings data on Friday, February 27th. The oil and gas company reported $0.44 earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.63. Delek US had a negative return on equity of 13.55% and a negative net margin of 0.21%.The firm had revenue of $2.43 billion during the quarter, compared to the consensus estimate of $2.55 billion. During the same period in the previous year, the company posted ($2.54) earnings per share. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. On average, equities research analysts expect that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.

Delek US Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 9th. Stockholders of record on Monday, March 2nd will be issued a $0.255 dividend. The ex-dividend date is Monday, March 2nd. This represents a $1.02 annualized dividend and a dividend yield of 2.4%. Delek US’s payout ratio is currently -291.43%.

Analyst Ratings Changes

A number of research firms have weighed in on DK. Piper Sandler lowered their target price on Delek US from $47.00 to $40.00 and set a “neutral” rating for the company in a report on Thursday, January 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Delek US in a research report on Wednesday, January 21st. Morgan Stanley decreased their price objective on Delek US from $40.00 to $38.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 27th. Wells Fargo & Company raised their price objective on Delek US from $43.00 to $53.00 and gave the company an “overweight” rating in a research report on Monday, November 10th. Finally, Mizuho lifted their target price on Delek US from $45.00 to $51.00 and gave the company an “outperform” rating in a research note on Friday, December 12th. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $39.46.

Key Headlines Impacting Delek US

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: TD Cowen raised its price target from $28 to $44 (hold), narrowing upside uncertainty and signaling improving analyst visibility. Finviz
• Positive Sentiment: Quarterly results: Delek US reported a surprise EPS beat ($0.44 vs. est. -$0.19), which is supportive for the shares despite a slight revenue shortfall. (Source: company/market coverage)
• Positive Sentiment: Dividend declared: a $0.255 quarterly dividend (annualized $1.02, ~2.3% yield) payable March 9 — offers short-term income support for the stock.
• Neutral Sentiment: Institutional activity: several large funds have adjusted positions recently (mix of increases and new stakes); institutional ownership remains high (~97%), which can both stabilize and concentrate stock moves.
• Negative Sentiment: CEO sale: CEO Avigal Soreq sold 50,000 shares (~$2.05M at ~$41.08). Large insider sales from the CEO often trigger investor concern about timing and outlook. CEO Sale — SEC filing: Form 4
• Negative Sentiment: Additional insider selling: multiple executives and directors sold sizable stakes in early March (EVPs Reuven Spiegel — 20,000 sh; Joseph Israel — 38,000 sh; Directors Shlomo Zohar and William Finnerty also sold). The cluster of senior-level sales is adding downward pressure. Relevant SEC filings: Spiegel (Read More.), Israel (Read More.), Zohar (Read More.), Finnerty (Read More.).
• Negative Sentiment: Analyst moves mixed-to-negative: Citi and Piper Sandler trimmed price targets (to $33 and $40 respectively) and Weiss reiterated a sell — these downward revisions amplify selling pressure even as some shops (e.g., Mizuho) remain bullish.

Institutional Trading of Delek US

A number of institutional investors have recently made changes to their positions in the business. Royal Bank of Canada increased its position in Delek US by 18.4% during the 1st quarter. Royal Bank of Canada now owns 278,774 shares of the oil and gas company’s stock valued at $4,201,000 after buying an additional 43,379 shares in the last quarter. AQR Capital Management LLC purchased a new stake in shares of Delek US during the first quarter worth about $390,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Delek US by 3.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,190 shares of the oil and gas company’s stock valued at $560,000 after acquiring an additional 1,102 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Delek US by 3,979.8% during the first quarter. Jones Financial Companies Lllp now owns 20,399 shares of the oil and gas company’s stock valued at $307,000 after acquiring an additional 19,899 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Delek US by 7.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,871 shares of the oil and gas company’s stock valued at $2,213,000 after purchasing an additional 9,827 shares during the last quarter. Institutional investors and hedge funds own 97.01% of the company’s stock.

About Delek US

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.